chr16-686860-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032259.4(WDR24):c.1216G>A(p.Gly406Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000993 in 1,610,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_032259.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR24 | NM_032259.4 | c.1216G>A | p.Gly406Ser | missense_variant | 3/9 | ENST00000293883.9 | |
WDR24 | XM_047434767.1 | c.985G>A | p.Gly329Ser | missense_variant | 3/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR24 | ENST00000293883.9 | c.1216G>A | p.Gly406Ser | missense_variant | 3/9 | 1 | NM_032259.4 | P1 | |
WDR24 | ENST00000248142.7 | c.1606G>A | p.Gly536Ser | missense_variant | 7/13 | 5 | |||
WDR24 | ENST00000647644.1 | c.1438G>A | p.Gly480Ser | missense_variant | 4/10 | ||||
WDR24 | ENST00000567014.1 | n.70G>A | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152282Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000533 AC: 13AN: 243860Hom.: 0 AF XY: 0.0000525 AC XY: 7AN XY: 133264
GnomAD4 exome AF: 0.00000892 AC: 13AN: 1458212Hom.: 0 Cov.: 32 AF XY: 0.00000965 AC XY: 7AN XY: 725524
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152282Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74400
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at